Skip to main content

Provider Notice Issued 05/20/2020

Date:   May 20, 2020


To:       All Participating Pharmacies


Re:      Pharmacy – 90-Day Supply and Over-the-Counter Covered Products                    


This notice informs providers that medications in specified drug classes and certain over-the-counter (OTC) medications are temporarily covered, due to the COVID-19 public health emergency.


In a March 30, 2020 provider notice, the Department indicated it was reviewing potential additions to the 90-day supply list of maintenance medications. Medications in the following drug classes have been added and will be temporarily covered in a 90-day supply:


ADHD / Anti-Narcolepsy Agents: Misc                                              

Analgesics - Anti-Inflammatory: Nonsteroidal Anti-Inflammatory Agents (NSAIDs)          

Antianxiety Agents: Misc                                                                 

Antiasthmatic and Bronchodilator Agents: Leukotriene Modulators                         


Antidepressants: Misc                                                                    

Antidepressants: Selective Serotonin Reuptake Inhibitor (SSRIs)                         

Antidepressants: Selective Serotonin-Norepinephrine Reuptake Inhibitor (SNRIs)          

Antidiabetics: Combinations                                                             

Antidiabetics: Dipeptidyl Peptidase-4 (DPP-4) Inhibitors                                

Antidiabetics: Insulin                                                                   

Antidiabetics: Misc                                                                     


Antiparkinson and Related Therapy Agents                                                  

Antipsychotics / Antimanic Agents: Benzisoxazoles                                       

Antipsychotics / Antimanic Agents: Dibenzapines                                         

Antipsychotics / Antimanic Agents: Misc                                                  

Antipsychotics / Antimanic Agents: Quinolinone Derivatives                              

Antivirals: Antiretrovirals (HIV)                                                       

Cardiovascular Agents - Antihypertensives: Ace Inhibitor Combinations                   

Cardiovascular Agents - Antihypertensives: Ace Inhibitors                               

Cardiovascular Agents - Antihypertensives: Angiotensin II Receptor Blocker Combinations 

Cardiovascular Agents - Antihypertensives: Angiotensin II Receptor Blockers             

Cardiovascular Agents - Antihypertensives: Antiadrenergics                              

Cardiovascular Agents - Antihypertensives: Beta-Blocker Combinations                    

Cardiovascular Agents - Antihypertensives: Beta-Blockers                                

Cardiovascular Agents - Antihypertensives: Calcium Channel Blockers                     

Cardiovascular Agents - Antihypertensives: Misc                                          

Cardiovascular Agents - Cardiotonics: Cardiac Glycosides                                

Cardiovascular Agents: Antianginal Agents                                               

Cardiovascular Agents: Antiarrhythmics                                                   

Cardiovascular Agents: Diuretics                                                        

Cardiovascular Agents: Misc                                                             

Endocrine and Metabolic Agents: Bone Density Regulators                                 

Endocrine and Metabolic Agents: Misc                                                    

Genitourinary Agents: Prostatic Hypertrophy Agents                                      

Gout Agents                                                                               

Psychotherapeutic and Neurological Agents: Antidementia Agents                          

Thyroid Agents                                                                           

Urinary Antispasmodics                                                               


Additionally, the following OTC products are temporarily available for all age groups:



Dextromethorphan HBr






Coverage is limited to drugs made by manufacturers who participate in the federal Medicaid Drug Rebate Program. Additional detail about specific medications temporarily covered in a 90-day supply is contained in the document, “Drugs Covered in 90-Day Supplies During COVID-19 Emergency”, on the Department’s COVID-19 Webpage.


Questions regarding this notice may be directed to a pharmacy consultant at 877-782-5565.



Kelly Cunningham

Interim Medicaid Administrator